Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression

This article has been updated

Abstract

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are involved in tumour progression and metastasis. In this study, we investigated the in vitro and in vivo expression patterns of MMP-1, MMP-2, MMP-3, MMP-9, TIMP-1 and TIMP-2 mRNA and protein in a previously described human melanoma xenograft model. This model consists of eight human melanoma cell lines with different metastatic behaviour after subcutaneous (s.c.) injection into nude mice. MMP-1 mRNA was detectable in all cell lines by reverse transcription polymerase chain reaction (RT-PCR), but the expression was too low to be detected by Northern blot analysis. No MMP-1 protein could be found using Western blotting. MMP-2 mRNA and protein were present in all cell lines, with the highest expression of both latent and active MMP-2 in the highest metastatic cell lines MV3 and BLM. MMP-3 mRNA was expressed in MV3 and BLM, and in the non-metastatic cell line 530, whereas MMP-3 protein was detectable only in MV3 and BLM. None of the melanoma cell lines expressed MMP-9. TIMP-1 and TIMP-2 mRNA and protein, finally, were present in all cell lines. A correlation between TIMP expression level and metastatic capacity of cell lines, however, was lacking. MMP and TIMP mRNA and protein expression levels were also studied in s.c. xenograft lesions derived from a selection of these cell lines. RT-PCR analysis revealed that MMP-1 mRNA was present in MV3 and BLM xenografts, and to a lesser extent in 530. Positive staining for MMP-1 protein was found in xenograft lesions derived from both low and high metastatic cell lines, indicating an in vivo up-regulation of MMP-1. MMP-2 mRNA was detectable only in xenografts derived from the highly metastatic cell lines 1F6m, MV3 and BLM. In agreement with the in vitro results, the highest levels of both latent and activated MMP-2 protein were observed in MV3 and BLM xenografts. With the exception of MMP-9 mRNA expression in 530 xenografts, MMP-3, MMP-9, and TIMP-1 mRNA and protein were not detectable in any xenograft, indicating a down-regulated expression of MMP-3 and TIMP-1 in vivo. TIMP-2 mRNA and protein were present in all xenografts; interestingly, the strongest immunoreactivity of tumour cells was found at the border of necrotic areas. Our study demonstrates that of all tested components of the matrix metalloproteinase system, only expression of activated MMP-2 correlates with increased malignancy in our melanoma xenograft model, corroborating an important role of MMP-2 in human melanoma invasion and metastasis.

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  1. Ahonen, M, Baker, AH & Kahari, VM (1998) Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 58: 2310–2315

    CAS  PubMed  Google Scholar 

  2. Butler, GS, Butler, MJ, Atkinson, SJ, Will, H, Tamura, T, van-Westrum, SS, Crabbe, T, Clements, J, d’Ortho, MP & Murphy, G (1998) The TIMP2 membrane type 1 metalloproteinase ‘receptor’ regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 273: 871–880

    CAS  Article  Google Scholar 

  3. Chambers, AF & Matrisian, LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260–1270

    CAS  Article  Google Scholar 

  4. Coussens, LM & Werb, Z (1996) Matrix metalloproteinases and the development of cancer. Chem Biol 3: 895–904

    CAS  Article  Google Scholar 

  5. Durko, M, Navab, R, Shibata, HR & Brodt, P (1997) Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1. Biochim Biophys Acta 1356: 271–280

    CAS  Article  Google Scholar 

  6. Ferrier, CM, van Geloof, WL, de Witte, HH, Kramer, MD, Ruiter, DJ & van Muijen, GN (1998) Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques. J Histochem Cytochem 46: 469–476

    CAS  Article  Google Scholar 

  7. Gomez, DE, Alonso, DF, Yoshiji, H & Thorgeirsson, UP (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74: 111–122

    CAS  PubMed  Google Scholar 

  8. Grant, GM, Cobb, JK, Castillo, B & Klebe, RJ (1996) Regulation of matrix metalloproteinases following cellular transformation. J Cell Physiol 167: 177–183

    CAS  Article  Google Scholar 

  9. Heppner, KJ, Matrisian, LM, Jensen, RA & Rodgers, WH (1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149: 273–282

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Imren, S, Kohn, DB, Shimada, H, Blavier, L & DeClerck, YA (1996) Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res 56: 2891–2895

    CAS  PubMed  Google Scholar 

  11. Kanayama, H, Yokota, K, Kurokawa, Y, Murakami, Y, Nishitani, M & Kagawa, S (1998) Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer 82: 1359–1366

    CAS  Article  Google Scholar 

  12. Khokha, R (1994) Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 86: 299–304

    CAS  Article  Google Scholar 

  13. Khokha, R, Zimmer, MJ, Wilson, SM & Chambers, AF (1992) Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis 10: 365–370

    CAS  Article  Google Scholar 

  14. Lambert, K, Machein, U, Machein, MR, Conca, W, Peter, HH & Volk, B (1998) Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am J Pathol 153: 429–437

    Article  Google Scholar 

  15. MacDougall, JR & Matrisian, LM (1995) Contribution of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14: 351–362

    CAS  Article  Google Scholar 

  16. MacDougall, JR, Bani, MR, Lin, Y, Rak, J & Kerbel, RS (1995) The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 55: 4174–4181

    CAS  PubMed  Google Scholar 

  17. Montgomery, AM, Mueller, BM, Reisfeld, RA, Taylor, SM & DeClerck, YA (1994) Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 54: 5467–5473

    CAS  PubMed  Google Scholar 

  18. Mueller, BM (1996) Different roles for plasminogen activators and metalloproteinases in melanoma metastasis. Curr Top Microbiol Immunol 213: 65–80

    CAS  PubMed  Google Scholar 

  19. Nagase, H (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378: 151–160

    CAS  PubMed  Google Scholar 

  20. Nakahara, H, Howard, L, Thompson, EW, Sato, H, Seiki, M, Yeh, Y & Chen, WT (1997) Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA 94: 7959–7964

    CAS  Article  Google Scholar 

  21. Newell, KJ, Witty, JP, Rodgers, WH & Matrisian, LM (1994) Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 10: 199–206

    CAS  Article  Google Scholar 

  22. Nielsen, BS, Timshel, S, Kjeldsen, L, Sehested, M, Pyke, C, Borregaard, N & Dano, K (1996) 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 65: 57–62

    CAS  Article  Google Scholar 

  23. Nomura, H, Sato, H, Seiki, M, Mai, M & Okada, Y (1995) Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55: 3263–3266

    CAS  PubMed  Google Scholar 

  24. Ray, JM & Stetler Stevenson, WG (1995) Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J 14: 908–917

    CAS  Article  Google Scholar 

  25. Sato, H, Takino, T, Okada, Y, Cao, J, Shinagawa, A, Yamamoto, E & Seiki, M (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61–65

    CAS  Article  Google Scholar 

  26. Sreenath, T, Matrisian, LM, Stetler, SW, Gattoni, CS & Pozzatti, RO (1992) Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Res 52: 4942–4947

    CAS  PubMed  Google Scholar 

  27. Stetler Stevenson, WG, Aznavoorian, S & Liotta, LA (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541–573

    CAS  Article  Google Scholar 

  28. Strongin, AY, Collier, I, Bannikov, G, Marmer, BL, Grant, GA & Goldberg, GI (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase. J Biol Chem 270: 5331–5338

    CAS  Article  Google Scholar 

  29. Sugiura, Y, Shimada, H, Seeger, RC, Laug, WE & DeClerck, YA (1998) Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res 58: 2209–2216

    CAS  PubMed  Google Scholar 

  30. Tokuraku, M, Sato, H, Murakami, S, Okada, Y, Watanabe, Y & Seiki, M (1995) Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 64: 355–359

    CAS  Article  Google Scholar 

  31. Vaisanen, A, Tuominen, H, Kallioinen, M & Turpeenniemi Hujanen, T (1996) Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol 180: 283–289

    CAS  Article  Google Scholar 

  32. Vaisanen, A, Kallioinen, M, Taskinen, PJ & Turpeenniemi-Hujanen, T (1998) Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma. J Pathol 186: 51–58

    CAS  Article  Google Scholar 

  33. Valente, P, Fassina, G, Melchiori, A, Masiello, L, Cilli, M, Vacca, A, Onisto, M, Santi, L, Stetler Stevenson, WG & Albini, A (1998) TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer 75: 246–253

    CAS  Article  Google Scholar 

  34. van den Oord, JJ, Paemen, L, Opdenakker, G & de Wolf Peeters, C (1997) Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol 151: 665–670

    CAS  PubMed  PubMed Central  Google Scholar 

  35. van Muijen, GN, Cornelissen, LM, Jansen, CF, Figdor, CG, Johnson, JP, Brocker, EB & Ruiter, DJ (1991a) Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice. Clin Exp Metastasis 9: 259–272

    CAS  Article  Google Scholar 

  36. van Muijen, GN, Jansen, KF, Cornelissen, IM, Smeets, DF, Beck, JL & Ruiter, DJ (1991b) Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int J Cancer 48: 85–91

    CAS  Article  Google Scholar 

  37. Westphal, JR, van’t Hullenaar, RG, van der Laak, JA, Cornelissen, IM, Schalkwijk, LJ, van Muijen, GN, Wesseling, P, de Wilde, PC, Ruiter, DJ & de Waal, RM (1997) Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. Br J Cancer 76: 561–570

    CAS  Article  Google Scholar 

  38. Wooley, DE & Grafton, CA (1980) Collagenase immunolocalization studies of cutaneous secondary melanomas. Br J Cancer 42: 260–265

    Article  Google Scholar 

  39. Yamamoto, M, Mohanam, S, Sawaya, R, Fuller, GN, Seiki, M, Sato, H, Gokaslan, ZL, Liotta, LA, Nicolson, GL & Rao, JS (1996) Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56: 384–392

    CAS  PubMed  Google Scholar 

  40. Zucker, S, Drews, M, Conner, C, Foda, HD, DeClerck, YA, Langley, KE, Bahou, WF, Docherty, AJP & Cao, J (1998) Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273: 1216–1222

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to U B Hofmann.

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and Permissions

About this article

Cite this article

Hofmann, U., Westphal, J., Waas, E. et al. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer 81, 774–782 (1999). https://doi.org/10.1038/sj.bjc.6690763

Download citation

Keywords

  • matrix metalloproteinase (MMP)
  • tissue inhibitor of matrix metalloproteinases (TIMP)
  • melanoma
  • xenograft
  • invasion
  • metastasis

Further reading

Search

Quick links